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All the human homologs of the six subunits of Saccha-
romyces cerevisiae origin recognition complex have
been reported so far. However, not much has been re-
ported on the nature and the characteristics of the hu-
man origin recognition complex. In an attempt to purify
recombinant human ORC from insect cells infected with
baculoviruses expressing HsORC subunits, we found
that human ORC2, -3, -4, and -5 form a core complex.
HsORC1 and HsORC6 subunits did not enter into this
core complex, suggesting that the interaction of these
two subunits with the core ORC2–5 complex is ex-
tremely labile. We found that the C-terminal region of
ORC2 interacts directly with the N-terminal region of
ORC3. The C-terminal region of ORC3 was, however,
necessary to bring ORC4 and ORC5 into the core com-
plex. A fragment containing the N-terminal 200 residues
of ORC3 (ORC3N) competitively inhibited the ORC2-
ORC3 interaction. Overexpression of this fragment in
U2OS cells blocked the cells in G1, providing the first
evidence that a mammalian ORC subunit is important
for the G1-S transition in mammalian cells.
Origin recognition complex (ORC)1 was first described in
yeast Saccharomyces cerevisiae (1). All six subunits, essential
for cell viability, collectively bind to the ARS (autonomously
replicating sequence) consensus sequence in a sequence-spe-
cific manner and lead to the chromatin loading of other repli-
cation factors like CDC6 and MCM (mini-chromosome mainte-
nance) that are essential for initiation of DNA replication (2, 3).
Similar six protein complexes have been discovered in Xenopus
laevis (4), Drosophila melanogaster (5) and Schizosaccharomy-
ces pombe (6), although a consensus DNA sequence that serves
as an origin of replication and where ORC may bind has not
been found in these species. Conservation of similar ORC sub-
units in mammals suggests that ORC has an equally important
role in mammalian cells.
Although all six human homologs of yeast S. cerevisiae ORC
subunits have been reported (7–14), purification of a six-pro-
tein human origin recognition complex remains elusive. Endog-
enous ORC2, -3, -4, and -5 subunits have been reported to
interact with each other in extracts of cancer cell lines (14).
ORC1 and ORC6 did not interact with other ORC subunits
under these experimental conditions (14). Therefore it is pos-
sible that a functional human ORC exists only during a very
short period of the cell cycle or in a specific sub-nuclear com-
partment, making it difficult to extract such a complex from
human cell lines. In fact, in a recent study hamster ORC1 was
reported to be easily eluted from chromatin during mitosis and
early G1 phase (15). It became stably bound to chromatin again
during mid-G1 phase with the appearance of a functional pre-
replication complex at a hamster replication origin. In contrast,
ORC2 was stably bound to chromatin throughout the cell cycle.
Difficulties in obtaining six protein human ORCs may also be
attributed to the fact that we are still missing some of the
unidentified important components of the human ORC. Indeed,
immunoprecipitation from [35S]methionine-labeled HeLa cell
lysate of ORC1, -2, -3, -4, and -6 showed many non-ORC pro-
teins interacting specifically with the respective ORC subunits
(14, 16).
A six protein ORC has been purified from Drosophila embryo
extracts and possesses some demonstrated biochemical activities
(5, 17, 18). All six Drosophila ORC subunits were expressed and
subsequently purified to homogeneity from baculovirus-infected
insect cells (17). Using an in vitro transcription translation reac-
tion, a similar six-protein ORC has been reported in yeast S.
pombe (6). With all the six human ORC subunits in our hand, we
attempted to produce recombinant human ORC from the bacu-
lovirus expression system in order to dissect the activities and
architecture of human origin recognition complex/subcomplex(s).
Because genetic experiments are difficult to perform in mam-
malian systems, the human ORC subunits have not been
shown to have a role in replication or cell proliferation. Utiliz-
ing knowledge learned about the architecture of the human
ORC, we created a dominant negative ORC subunit designed to
disrupt the formation of endogenous ORC. Overexpression of
this dominant negative ORC subunit blocked the cell cycle in
G1, providing the first evidence of the importance of ORC in
cancer cell proliferation.
MATERIALS AND METHODS
Plasmid Constructions—Cloning of ORC1–6 cDNAs are described
elsewhere (7, 9–11, 14). Coding sequences of ORC1, ORC4, ORC5,
ORC6, and ORC3N200 were cloned into pFastBac (Life Technologies,
Inc.), and coding sequences of ORC2 and ORC3 were cloned into pFast-
Bac Dual. ORC2, -4, and -5 were also cloned in pFB-GST vectors to
express GST fusion proteins. ORC3 and all the related constructs for in
vitro transcription and translation reactions were made into
T7T3DPAC vector (GenBankTM accession number U13871). Full-length
and C-terminal ORC2 fragments were cloned into pGEX-5X-3 (Invitro-
gen) to produce bacterial fusion proteins. Additional information re-
garding the constructs will be made available upon request.
Expression of ORC Subunits in Insect Cells, Purification, and Gel
Filtration—Baculoviruses were produced from the recombinant pFast-
Bac or pFB-GST plasmids using the Bac-to-Bac expression system (Life
Technologies, Inc.). Hi5 or Sf9 cells (Invitrogen) were infected with
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these baculoviruses according to the manufacturers’ recommendations.
Cells were harvested 48 h post-infection. The cell pellet was washed
once in cold phosphate-buffered saline and subsequently resuspended
in hypotonic lysis buffer (10 mM Tris/Cl, pH 7.9, 10 mM KCl, 1.5 mM
MgCl2,1 mM phenylmethylsulfonyl fluoride, 2 mg/ml pepstatin, 2 mg/ml
leupeptin, 5 mg/ml aprotinin, 1 mM dithiothreitol). The cell suspension
was homogenized in a Dounce homogenizer using a B-type pestle fol-
lowed by centrifugation at 3000 rpm for 7 min. The pellet containing the
nuclei was lysed in buffer H/0.15 (50 mM HEPES/KOH, pH 7.5, 150 mM
KCl, 0.02% Nonidet P-40, 5 mM magnesium acetate, 1 mM EDTA, 1 mM
EGTA, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride, 2 mg/ml
pepstatin, 2 mg/ml leupeptin, 5 mg/ml aprotinin, 1 mM dithiothreitol).
The resulting suspension was subjected to ammonium sulfate precipi-
tation (starting with 10% followed by 30% and finally 50%). The pellet
after the 50% ammonium sulfate cut was resuspended in buffer H/0.0
(no salt) and then dialyzed overnight against buffer H/0.15. The dia-
lyzed sample was then bound to GST beads (Sigma) and washed three
times with buffer H/0.25. Proteins were eluted using reduced glutathi-
one elution buffer (50 mM Tris/Cl, pH 8.0, 20 mM reduced glutathione,
0.01% Nonidet P-40, 100 mM NaCl). Gel filtration of glutathione eluate
using a fast protein liquid chromatography Superose 12 (Amersham
Pharmacia Biotech) column was performed as described previously (14).
Cell Culture, Transfection, Immunoblotting, Immunoprecipitation,
and Silver Stain—Sf9 and Hi5 cells were maintained according to the
manufacturers’ protocol (Invitrogen). U2OS cells used for FACS anal-
ysis were maintained in Dulbecco’s modified Eagle’s medium with 10%
fetal bovine serum (Life Technologies, Inc.). Plasmid DNA used for
transfection were purified using Qiagen maxiprep kits. Cells were
grown in 100-mm dishes and transfected using LipofectAMINE (Life
Technologies, Inc.). Western blotting and immunoprecipitation tech-
niques were carried out using standard protocols. Anti-GST polyclonal
antibodies were purchased from Santa Cruz Biotechnologies. Antibod-
ies against HsORC1–6 have been described previously (9–11, 14). The
silver stain method has been described elsewhere (19).
In Vitro Transcription and Translation Reactions and GST Pull-
down Assay—In vitro transcription and translation reactions to produce
[35S]methionine-labeled full-length and different deletions of ORC3
were performed using the Promega TNT system (Madison, WI). Pull-
down assays on glutathione-agarose beads were done as described
previously (20).
FACS Analysis—U2OS cells were transfected with farnesylated GFP
(CLONTECH) alone or in combination with FLAGORC2, GFPC1-
ORC3N, or GFPC1-ORC3C1. Forty-eight hours after transfection, cells
were trypsinized, washed with phosphate-buffered saline, fixed with
cold 70% ethanol, and stored until further use. Before analysis, fixed
cells were resuspended in phosphate-buffered saline containing 50
mg/ml propidium iodide (Sigma), 10 mg/ml RNaseA (Sigma), and 0.05%
Noniodet P-40 and then incubated for 1 h at 4 °C. Finally cells were
washed in phosphate-buffered saline and analyzed by flow cytometry.
The data were further analyzed using FLOWJO software to calculate
the percentage of cells residing in different cell cycle stages.
RESULTS
GSTORC5, -2, -3, and -4 Forms a Complex—ORC2, -3, -4,
and -5 subunits have been shown to interact with each other in
human cell extracts (14). In an attempt to purify recombinant
six protein human origin recognition complex, we infected Sf9
insect cells with baculoviruses expressing human ORC1–6 sub-
units. One of the subunits, ORC5, was GST-tagged. After pull
down on glutathione beads, we found that GSTORC5, -2, -3,
and -4 can be purified as a complex (Fig. 1A). ORC1 did not
enter into the complex in a stoichiometric ratio, and the pres-
ence of very little ORC1 in Fig. 1A was not reproducible in
different preparations. ORC6 did not enter into the complex at
all. Both ORC1 and ORC6 were expressed at a high level. In a
control experiment, we expressed GST alone with other ORC
subunits. Pull down on glutathione beads purified only GST
but none of the ORC subunits. Therefore, the results in Fig. 1A
are due to the formation of a complex of ORC2, -3, -4, and -5 and
not due to precipitation of the proteins on the glutathione
beads. GST pull-down experiments using GST tags on different
ORC subunits (GSTORC2 and GSTORC4) confirmed the pre-
vious result showing ORC2, -3, -4, and -5 form a core complex
(data not shown).
To further show that GSTORC5, -2, -3, and -4 subunits are in
one complex, we analyzed the elution pattern of these proteins
upon gel filtration. Proteins were eluted from the GST beads
using reduced glutathione and subsequently passed through a
Superose 12 gel filtration column. Upon Western blotting of
different fractions with different anti-ORC antibodies, we
found that GSTORC5, -2, -3, and -4 subunits were co-eluted in
one fraction (Fig. 1C). The molecular mass of this complex is
;500 kDa, which is more than the combined molecular mass of
the four ORC subunits. This may be because of the multimer-
ization of the GST moieties to give a high molecular mass
complex or because the complex has an atypical shape. Silver
staining of the purified protein used for the gel filtration ex-
periment indicated that GST-ORC5, ORC2, -3, and -4 were the
only proteins present in the preparation in significant amounts
(Fig. 1D).
ORC2 and ORC3 Physically Interact with Each Other—We
were interested in seeing which of the four interacting subunits
interact directly. Sf9 insect cells were infected with six differ-
ent combinations of baculoviruses expressing two ORC sub-
units in each case. One of the two viruses was GST-tagged.
Affinity purification on glutathione beads showed that only
ORC2 and ORC3 directly interacted with each other (Fig. 2).
None of the other dual combinations of baculovirus showed any
interaction under our experimental conditions. Therefore, we
conclude that ORC2 and ORC3 form a core component of the
ORC2, -3, -4, -5 complex.
ORC2 and ORC3 Recruit ORC4 and -5—The ORC2-3 com-
plex is expected to recruit ORC4 and ORC5. We were interested
in seeing whether ORC2-3 core complex can recruit ORC4 first,
followed by ORC5, or vice versa. Sf9 cells were infected by
baculoviruses expressing GSTORC4, -2, and -3 subunits or by
viruses expressing GSTORC5, -2, and -3. GSTORC4 did not
FIG. 1. Human ORC2–5 co-purify in a complex. A, Sf9 insect cells
were infected with baculoviruses expressing ORC1, -2, -3, -4, -6 and
GSTORC5. Proteins were purified as described under “Materials and
Methods.” Both purified proteins and crude lysate (Input) were immu-
noblotted using ORC1–6 antibodies. B, Sf9 insect cells were infected
the same way as in A using baculoviruses expressing ORC2–5 and GST
as control. The cell lysate was purified on GST beads and immuno-
blotted. C, Sf9 insect cells were infected with baculoviruses expressing
ORC2, -3, -4 and GST-ORC5. Proteins purified on GST beads were
fractionated on a Superose 12 gel filtration column. Alternate fractions
were immunoblotted using anti-ORC2, -3, -4 and anti-GST antibodies.
The positions of the molecular mass markers thyroglobulin (670 kDa),
bovine gamma globulin (158 kDa), and chicken ovalbumin (44 kDa) are
shown on top. Input lanes were loaded with 5% of the total lysate passed
through the column.
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interact with ORC2 and ORC3, whereas GSTORC5 interacted
with ORC2 and ORC3 (Fig. 3). Therefore, ORC2-3 core complex
is capable of recruiting ORC5, but it cannot recruit ORC4 by
itself. The fact that ORC2, -3, -4, and -5 form a complex sug-
gests that ORC2, -3, and -5 complex is necessary to load ORC4.
It is also possible that ORC4 and ORC5 can be loaded on
ORC2-3 core complex simultaneously independent of each
other, but ORC5 is necessary to stabilize the association of
ORC4 with the other ORC subunits.
N-terminal Portion of ORC3 Interacts with the C-terminal
Portion of ORC2—Upon establishing the fact that ORC2 and
ORC3 form a core complex, we mapped the interacting domains
of ORC2 and ORC3. N-terminal fragments of ORC3 labeled
with [35S]methionine were produced by in vitro transcription
and translation in rabbit reticulocyte lysate. The proteins were
incubated with bacterially expressed and purified GSTORC2
protein. Three polypeptides derived from ORC3 were capable of
binding GSTORC2, whereas the control GST protein did not
bind any of them (Fig. 4A). The smallest fragment that bound
to ORC2 contained 200 amino acids from the N terminus of
ORC3 (construct 3, ORC3N). To map the portion of ORC2
involved in the interaction with ORC3, we expressed and pu-
rified GSTORC2C, containing the C-terminal 225 amino acids
of ORC2. Both full-length ORC3 and ORC3N bound to
GSTORC2C (Fig. 4B), whereas control GST alone did not bind
to any one of them (data not shown). Therefore, the C-terminal
225 residues of ORC2 interact with the N-terminal 200 resi-
dues of ORC3 to form the ORC2-3 complex at the core of human
ORC. In the reciprocal deletion, removal of the first 200 amino
acids of ORC3 abolished its ability to bind to GSTORC2 (Fig. 4C).
Based on these results we conclude that N-terminal 200 residues
of ORC3 are necessary and sufficient to interact with ORC2.
N-terminal 200 Amino Acids of ORC3 Can Compete with the
Full-length ORC3—If the N-terminal 200 residues of ORC3 are
sufficient for binding ORC2, ORC3N might be able to compete
with full-length ORC3 for binding to GSTORC2. [35S]Methi-
onine-labeled ORC3 was bound to GSTORC2 beads under con-
ditions where the latter was limiting. These beads were then
incubated with increasing amounts of ORC3N. We found that
ORC3N protein could compete with the full-length ORC3 pro-
tein for association with GSTORC2 (Fig. 5).
ORC3N Cannot Form a Complex That Contains ORC4-5—
Next we asked whether ORC3N is capable of mediating the
interaction of ORC2 with ORC4 and ORC5. Sf9 insect cells
were infected with baculoviruses expressing GSTORC5, ORC2,
ORC4, and ORC3N. After affinity purification on glutathione
beads and Western blotting, we confirmed the presence of
GSTORC5 in the eluate from the beads. Interestingly, in con-
trast to the result in Fig. 1A, none of the other ORC subunits
came down with GSTORC5, although they were all present in
the input lane at reasonable quantities (Fig. 6A). We confirmed
the physical interaction between ORC2 and ORC3N in the
insect cell lysates by co-immunoprecipitation reactions. The
lysate was immunoprecipitated using either anti-ORC2 or anti-
FIG. 2. Direct interaction between ORC2 and ORC3 subunits.
Sf9 insect cells were infected with six different combinations of bacu-
loviruses expressing two ORC subunits in each case (GSTORC2-3
(GSTO2103), GSTORC5-3 (GSTO5103), GSTORC5-4 (GSTO5104),
GSTORC5-2 (GSTO5102), GSTORC4-2 (GSTO4102), and GSTORC4-3
(GSTO4103)). Proteins bound to GST beads were immunoblotted using
either anti-GST antibody or respective anti-ORC antibodies. 5% of the
total lysate was loaded in the input lanes.
FIG. 3. ORC2-3 subcomplex can load ORC5 but not ORC4. Sf9
insect cells were infected either with baculoviruses expressing
GSTORC5-2-3 (GSTORC51213) or baculoviruses expressing
GSTORC4-2-3 (GSTORC41213). Proteins bound to GST beads were
immunoblotted using either anti-GST antibodies or respective anti-
ORC antibodies. Input (Inp.) lane contains 5% of proteins input on GST
beads.
FIG. 4. Mapping domains of interactions between ORC2 and
ORC3. A, full-length ORC3 or different N-terminal deletions of ORC3
were produced using in vitro transcription and translation reactions
and tested for their ability to bind either GST or GSTORC2 in a
pull-down experiment on glutathione-agarose beads coated with GST,
GSTORC2 (GSTO2). In each case, the input lanes were loaded with 5%
of the amount of the labeled protein incubated with the beads. The
labeled proteins were visualized by SDS-polyacrylamide gel electro-
phoresis followed by fluorography. B, GST pull-down experiment as in
A using GSTORC2C (C-terminal portion of ORC2) and in vitro tran-
scribed and translated full-length ORC3 (1) or ORC3N200 (3). C, full-
length ORC3 or different C-terminal deletions of ORC3 were produced
using in vitro transcription translation reaction. GST pull-down exper-
iments were performed as shown in Fig. 5A using either GST or
GSTORC2.
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ORC3 antibodies followed by immunoblotting with both the
antibodies. ORC2 was detected in anti-ORC3 immunoprecipi-
tate and vice versa (Fig. 6B). Therefore, ORC3N is capable of
interacting with ORC2, but this interaction was not sufficient
for further binding of ORC4 and ORC5. The C-terminal portion
of ORC3 appears to be crucial for binding of ORC4 and ORC5
subunits to ORC2-3 subcomplex.
Expression of ORC3N in U2OS Cells Causes Cell Cycle Ar-
rest—Because ORC3N did not form a complex with ORC4 and
ORC5 but still could interact with ORC2, we reasoned that
ORC3N might show a dominant negative effect on the cell cycle
if overexpressed in a human cancer cell line. ORC3N and
ORC3C1 were cloned into GFPC1 (CLONTECH) expression
vector to produce non-farnesylated GFP fusion proteins. U2OS
cells were transfected with plasmids expressing farnesylated
GFP alone or in combination with FLAGORC2 or GFPORC3N
or GFPORC3C1 (1:3 molar ratio) followed by FACS analysis
after 48 h. Cells transfected with GFP alone, FLAG-ORC2, or
GFP-ORC3C1 showed normal cell cycle progression, whereas
cells transfected with GFP-ORC3N were blocked mostly in G1
(73%) (Fig. 7). This is the first evidence for any cell cycle effect
of any human ORC protein. Since ORC3N can still bind ORC2
but not ORC4 and ORC5, it is possible that over-expressed
ORC3N interacts with ORC2 but prevents functional ORC
formation. Consistent with this, over-expression of full-length
ORC3, which interacts with ORC2 but allows functional ORC
formation, did not block the cells in G1 (data not shown).
DISCUSSION
We report here that human ORC2, -3, -4, and -5 form a core
complex in baculovirus-infected insect cells. ORC1 and ORC6
did not interact with this core complex under these experimen-
tal conditions. This was confirmed by using different tags on
different ORC subunits and is consistent with our previously
published data showing that endogenous ORC2, -3, -4, and -5 in
a HeLa cell extract physically interacted with each other but
not with ORC1 and -6(14). Recently ORC1 has been shown to
interact with ORC2 by co-immunoprecipitation reaction using
high salt nuclear lysate from HeLa cells (21). This study did not
include ORC3-6 proteins. Unfortunately, we could not repro-
duce the co-immunoprecipitation of ORC1 with ORC2 in hu-
man cell lines using two different ORC1 antibodies, raised
independently. Under the same conditions we still found strong
interaction among ORC2–5 subunits. The data from HeLa cell
extract and recombinant baculovirus proteins strongly suggest
that ORC2–5 form a core complex with ORC1 and ORC6, joining
the complex either at very restricted times or locations or in a
very labile interaction that is easily disrupted upon cell lysis.
We further found that ORC2 and ORC3 form a tight complex
essential for binding ORC4 and ORC5. Gel filtration of 293T cell
extract showed that ORC2 and 3 were the only two subunits that
FIG. 5. ORC3N can compete with full-length ORC3. GSTORC2
beads were incubated with in vitro transcribed and translated full-
length ORC3. After incubation, beads were thoroughly washed using
binding buffer and incubated again with increasing amount of in vitro
transcribed and translated ORC3N200. Beads were finally washed, and
bound labeled proteins were visualized by SDS-polyacrylamide gel elec-
trophoresis followed by fluorography.
FIG. 6. ORC3N does not form a complex with ORC2, -4, and -5.
A, Sf9 insect cells were infected with baculoviruses expressing
GSTORC5, -2, -4 and ORC3N200. Proteins bound to glutathione-agar-
ose beads were immunoblotted using either anti-GST or anti-ORC
antibodies. B, immunoprecipitation using anti-ORC2 and anti-ORC3
antibodies. Insect cell lysate from A was immunoprecipitated (IP) using
either anti-ORC2 or anti-ORC3 antibodies followed by immunoblotting
(IB) with either anti-ORC3 or anti-ORC2 antibodies. In each case 5% of
the lysate (used for immunoprecipitation) was loaded in the input (Inp)
lanes. Sera used for immunoprecipitation: I, immune, and PI, preimmune.
FIG. 7. FACS analysis of U2OS cells transfected with different
constructs. U2OS cells were transfected either with farnesylated GFP
(CLONTECH) or in combination with FLAGORC2, GFPORC3N, or
GFPORC3C1. Transfected cells were fixed and stained with propidium
iodide and then analyzed by FACS. The percentage of cell population
present at different cell cycle stages in each transfection is shown at the
bottom of the each panel.
FIG. 8. Model of human ORC2–5 subcomplex. Human ORC sub-
units are showed as numbers 1–6. ORC2–5 subunits are shown to form
a complex. N and C in ORC2 and -3 depict N- and C-terminal residues
of the individual subunits. The arrow with the bold line shows a strong
interaction, whereas arrows with dotted lines indicate weak
interactions.
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mostly co-eluted, consistent with the direct interaction between
ORC2 and -3 reported here (16). Under our experimental condi-
tions, none of the other ORC subunits interact with each other
directly. The N-terminal 200 amino acids of ORC3 were enough
to interact with C-terminal portion of ORC2 but not sufficient to
allow association with ORC4 and ORC5, suggesting that the
C-terminal of ORC3 is required for ORC4 and ORC5 loading on
ORC2-3 subcomplex.
Recently, in yeast S. cerevisiae, ORC2 and ORC3 have been
shown to interact directly (22). Insect cells were infected with
baculoviruses expressing yeast ORCs, and recombinant yeast
ORC was purified and tested for its DNA binding ability. ORC6
was found dispensable for DNA binding property. Elimination
of ORC3 during baculovirus infection led to formation of ORC
sub-complex without the presence of ORC2, suggesting that
yeast ORC3 recruits ORC2 to the complex. Likewise, yeast
ORC4 and ORC5 were shown to interact with each other. In
addition, when yeast ORC was bound to yeast ARS1, ORC1, -2,
-4, and -5 subunits were shown to directly contact ARS1 DNA
by UV cross-linking (22). The human ORC2–5 sub-complex,
however, did not show any sequence-specific DNA binding ac-
tivity (data not shown).
Finally we showed that ORC3N has a dominant negative
effect on cell cycle progression. U2OS cells expressing the same
fragment were blocked in G1, whereas the ORC3C1 or ORC2
protein did not prevent the cells from normal cell cycle progres-
sion. This can be explained by the fact that ORC3N titrates out
ORC2 or an unknown cellular protein in the cell, thereby block-
ing G1-S transition. Given that ORC2 and ORC3N form a very
tight complex but the latter cannot support ORC2, -3, -4, -5
complex formation, we believe that ORC2 is the target that is
titrated out by ORC3N. We cannot, however, overcome the
effect of ORC3N by over-expressing ORC2 or ORC2C.2 ORC2 or
ORC2C might not be expressed at high enough levels to titrate
out the ORC3N. Alternatively, the ORC3N targets an unknown
cellular factor to cause the G1-S block.
Based on these results we propose a molecular architecture
of human ORC (Fig. 8). ORC2 and ORC3 interact directly with
the C terminus of the former subunit, in close proximity with
the N terminus of the latter. This binding favors the loading of
ORC4 and -5 subunits via the C-terminal residues of ORC3.
Although none of the other ORC subunits interacted with each
other, we cannot rule out weak inter-subunit interactions
among themselves. Further experiments will address how the
ORC2–5 complex recruits ORC1 and ORC6 to form human
ORC and study how the complex interacts with DNA.
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